H47.239
Glaucomatous optic atrophy, unspecified eye
Clinical Classification Guidelines
Medical Intelligence & Overview
Glaucomatous optic atrophy refers to damage to the optic nerve caused primarily by glaucoma. This condition can lead to irreversible vision loss if not diagnosed and managed promptly. The term 'unspecified eye' indicates that the specific eye affected has not been identified. This article provides an overview of the causes, symptoms, diagnosis, and potential management options for this condition.
Causes & Symptoms
Clinical Causes: Elevated intraocular pressure, often associated with glaucoma Poor blood flow to the optic nerve Age-related degenerative changes in the optic nerve Genetic predisposition to optic nerve damage Vascular factors that affect optic nerve health
Key Symptoms: Gradual loss of peripheral vision Detection of blind spots in the visual field Patchy or asymmetric vision loss between eyes In advanced stages, decreased central vision Potential eye discomfort or light sensitivity
Diagnostic & Treatment
Diagnosis Path: Diagnosing glaucomatous optic atrophy involves a comprehensive eye examination. Ophthalmologists typically perform:
Treatment Protocols: While there is no cure for glaucomatous optic atrophy, treatment aims to slow the progression of optic nerve damage. Common approaches include:
Clinical Advice & FAQs
Billing Guidance
Is H47.239 a billable ICD-10 code?
Yes, H47.239 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H47.239?
Clinical documentation must specify the nature of Glaucomatous optic atrophy, unspecified eye and any associated comorbidities for accurate reporting.
Cite this Clinical Reference